Systemic oxidant stress, as indicated by serum sp-NOX2 and urinary 8-iso-PGF2 alpha, contributes to the progression of NAFLD through various mechanisms [60]. Here, CYBB is linked to metabolic dysfunction-associated steatotic liver disease.